2DDB - a bioinformatics solution for analysis of quantitative proteomics data. - Lars Malmström; György Marko-Varga; Gunilla Westergren-Thorsson; Thomas Laurell; Johan Malmström (BMC Bioinform., 2006)

BioBanking - The Holy Grail of novel drug and diagnostic developments? - György Marko-Varga (J. Clin. Bioinform., 2011)

Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study. - Masaharu Nomura; Tetsuya Fukuda; Kiyonaga Fujii; Takeshi Kawamura; Hiromasa Tojo; Makoto Kihara; Yasuhiko Bando; Adi F. Gazdar; Masahiro Tsuboi; Hisashi Oshiro; Toshitaka Nagao; Tatsuo Ohira; et al. (J. Clin. Bioinform., 2011)

Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels. - Melinda Rezeli; Ákos Végvári; Thomas E. Fehniger; Thomas Laurell; György Marko-Varga (J. Clin. Bioinform., 2011)

Biobank resources for future patient care: developments, principles and concepts. - Ákos Végvári; Charlotte Welinder; Henrik Lindberg; Thomas E. Fehniger; György Marko-Varga (J. Clin. Bioinform., 2011)